Viscosupplementation Market to Reach USD 9.4 Billion by 2034

Pune, India, November 2025 - According to a new report by Exactitude Consultancy, the global Viscosupplementation Market is expected to reach USD 9.4 billion by 2034, growing at a CAGR of 8.1% from 2025 to 2034. The market's expansion is fueled by the growing prevalence of osteoarthritis (OA), the increasing adoption of minimally invasive procedures, and technological advancements in long-acting hyaluronic acid (HA) formulations.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/49100

Key Takeaways
• The global viscosupplementation market was valued at USD 4.3 billion in 2024.
• Single-injection formulations are gaining rapid popularity due to enhanced convenience and reduced risk of infection.
• North America leads the global market, accounting for more than 45% of total revenue.
• Major companies include Sanofi, Anika Therapeutics Inc., Seikagaku Corporation, Fidia Farmaceutici S.p.A., Zimmer Biomet, and Bioventus Inc.
• Increasing adoption of next-generation cross-linked HA injectables is enhancing product performance and patient compliance.

Market Story
Viscosupplementation, a minimally invasive therapy that involves injecting hyaluronic acid into the knee joint to restore lubrication, is becoming an increasingly preferred treatment for osteoarthritis patients seeking pain relief and improved mobility.

As the aging population grows and sedentary lifestyles rise, osteoarthritis prevalence continues to increase globally. Manufacturers are investing in longer-lasting, high-purity HA products and biocompatible delivery systems to enhance patient outcomes. Additionally, ongoing clinical research in combination therapies-pairing HA with platelet-rich plasma (PRP) or corticosteroids-is broadening therapeutic potential.

The integration of AI-assisted diagnostics and digital joint monitoring platforms further supports personalized viscosupplementation treatment strategies.

Market Segmentation
By Product Type:
• Single Injection
• Three Injection
• Five Injection

By End User:
• Hospitals
• Orthopedic Clinics
• Ambulatory Surgical Centers
• Research & Academic Institutions

By Application:
• Knee Osteoarthritis
• Hip Osteoarthritis
• Shoulder Osteoarthritis
• Others

By Region:
• North America (U.S., Canada)
• Europe (Germany, UK, France, Italy, Spain)
• Asia-Pacific (China, Japan, India, South Korea, Australia)
• Latin America (Brazil, Mexico)
• Middle East & Africa

Explore Full Report here: https://exactitudeconsultancy.com/reports/49100/viscosupplementation-market

Recent Developments
• 2025: Anika Therapeutics launched an extended-release HA injection with dual crosslinking for sustained joint relief.
• 2024: Fidia Farmaceutici S.p.A. introduced a high-molecular-weight HA formulation for advanced osteoarthritis treatment.
• 2023: Bioventus Inc. completed FDA approval for its next-generation single-injection system.
• 2022: Zimmer Biomet expanded its viscosupplementation portfolio in the Asia-Pacific region through new distribution partnerships.

Expert Insight
"The viscosupplementation market is witnessing a paradigm shift toward more durable and patient-friendly therapies," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy. "With clinical innovation and greater global awareness, viscosupplementation is becoming an essential component of modern osteoarthritis management."

Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49100

Market Drivers
1. Increasing global burden of osteoarthritis due to aging demographics.
2. Rising preference for minimally invasive and non-surgical treatments.
3. Technological improvements in HA synthesis, purity, and molecular stability.
4. Expanding healthcare infrastructure and access to orthopedic care in emerging markets.

Forecast & Regional Insights
The North American market continues to dominate, driven by advanced orthopedic care systems, strong reimbursement policies, and a large base of osteoarthritis patients. Europe follows closely, supported by clinical research and widespread HA product availability. Meanwhile, the Asia-Pacific region is projected to grow at the fastest CAGR (9.4%) due to increasing healthcare expenditure and awareness in China, Japan, and India.

Conclusion
The Viscosupplementation Market is poised for steady expansion over the next decade, fueled by innovation in hyaluronic acid formulations and growing preference for minimally invasive joint therapies. With ongoing R&D, supportive government policies, and broader patient access, viscosupplementation will continue to play a central role in orthopedic pain management.

This report is also available in the following languages : Japanese (粘性補充療法), Korean (점성 보충), Chinese (粘液补充), French (viscosupplémentation), German (Viscosupplementation), and Italian (Viscosupplementazione), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/49100/viscosupplementation-market#request-a-sample

Related Reports

Orthopedic Joint Cavity Viscosupplementation Market
https://exactitudeconsultancy.com/reports/59780/global-orthopedic-joint-cavity-viscosupplementation-market

Viscosupplementation Injection Market
https://exactitudeconsultancy.com/reports/64080/global-viscosupplementation-injection-market

Orthopedic Devices Market
https://exactitudeconsultancy.com/reports/4319/orthopedic-devices-market

Hospital Mobile Xray Market
https://exactitudeconsultancy.com/reports/4489/hospital-mobile-x-ray-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.